ACADEMIC AND INDUSTRY HEALTH ALLIANCE TACKLE TOMORROW’S NATIONAL HEALTH CHALLENGES TODAY Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
With
Vishaal Kishore,
Professor of Innovation and Public Policy
RMIT University &
Executive Chair, RMIT-Cisco Health Transformation Lab &
Director – Impact, RMIT University, Melbourne
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | June 2025
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.
Last year a “Sandbox” was established to serve as a digitally rich collaboration and prototyping studio designed for privacy and security, ready to innovate in aged care and healthcare. The “Sandbox” housed at RMIT-Cisco’s Health Transformation Lab is a digitally-enabled mock care setting where researchers, startups and health system professionals work together on prototypes for the future of health. The Sandbox enables a frictionless pipeline from idea to implementation. The inclusion of autonomous robotics, has created a space where the most futuristic visions for health can be trialled, tested, and translated into practice.
The Health Transformation Lab emphasises user engagement, prioritising the voices of clients and clinicians to design solutions based on their needs rather than assumptions. This practice aims to ensure that any technology developed gains traction in health systems only if it genuinely reflects user requirements.
The NIIN Health Alliance has identified urgent needs in the healthcare system, considering the rapidly evolving technological landscape. As part of their strategic planning, they reviewed nearly 10,000 articles and reports to outline pivotal trends for the future in the publication “Health x Digital Transformation Report 2024-2025”.
In this report, a significant focus has been on the implications of augmented intelligence, remote patient monitoring, digital simulations, adaptable systems, and leveraging advancements in biotechnology, aiming to prepare the healthcare sector for emerging challenges and opportunities in the coming years.
Source: Written from transcript and health transformation lab website by AUDIENCED
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
-
Investigating use of dietary supplements for osteoarthritis
Osteoarthritis is a leading cause of disability affecting over 2 million Australians, according to Australian Institute of Health and Welfare report on Chronic musculoskeletal conditions (2024) and 595 million people globally, according to BD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020. It represents a significant public health burden that diminishes quality of life among ageing populations.
